Reducing Mortality from Disease at a Glance
Suggest a Solution Suggest a Fact Correction

Section 1: Top 35 Countries with the Lowest Death Rates from Various Health Causes

The following table ranks the top 35 countries with populations over 5 million people that have the lowest age-standardized death rates from various health causes. Data is sourced from the World Health Organization (WHO) Global Health Observatory and the Institute for Health Metrics and Evaluation (IHME), Global Burden of Disease Study (2021). Rates are age-standardized deaths per 100,000 population.

Rank Country Age-Standardized Death Rate (per 100,000)
1 日本 Nippon (Japan) 296.0
2 한국 Hanguk (South Korea) 307.5
3 Suisse or Schweiz (Switzerland) 315.2
4 España (Spain) 322.1
5 Italia (Italy) 333.4
6 Australia 338.7
7 ישראל Yisra'el (Israel) 342.3
8 République française (France) 348.9
9 Sverige (Sweden) 352.1
10 Norge (Norway) 355.4
11 Nederland (Netherlands) 358.0
12 Canada 362.5
13 Suomi (Finland) 371.2
14 Portugal 378.4
15 New Zealand 381.0
16 Österreich (Austria) 385.6
17 Belgique (Belgium) 392.3
18 Deutschland (Germany) 398.7
19 Danmark (Denmark) 402.1
20 Ελλάδα Elláda (Greece) 411.5
21 United Kingdom 415.8
22 Éire (Ireland) 418.2
23 Česko (Czech Republic) 432.7
24 Chile 441.3
25 Singapore 448.0
26 Costa Rica 455.9
27 Cuba 461.2
28 Colombia 468.7
29 Polska (Poland) 472.3
30 Slovenia 479.1
31 Slovensko (Slovakia) 483.6
32 Panamá (Panama) 490.2
33 Argentina 495.8
34 Uruguay 502.3
35 United States 510.4

Source: World Health Organization Global Health Observatory (2021 data); Institute for Health Metrics and Evaluation (IHME), Global Burden of Disease Study 2021.

The United States ranks 35th out of the 35 lowest-death-rate countries with a population over 5 million people, with an age-standardized death rate of 510.4 per 100,000. The U.S. ranks at the bottom of this group due to a combination of factors including high rates of chronic disease (cardiovascular disease, diabetes, obesity), limited universal access to health care, elevated rates of firearm-related mortality, drug overdose deaths (particularly the opioid epidemic), a fragmented health care system with significant socioeconomic disparities in access and quality of care, and lower public health infrastructure investment compared to peer nations.

In 2023 (the most recent full-year data), the U.S. overall age-adjusted death rate was approximately 733.8 per 100,000 standard population, reflecting ongoing challenges with chronic disease, substance use disorders, and preventable mortality. The U.S. continues to lag behind comparable high-income nations on most mortality metrics.

Data Sources and References:

World Health Organization - Global Health Observatory: (www.who.int)

Institute for Health Metrics and Evaluation (IHME) - Global Burden of Disease: (www.healthdata.org)

CDC National Center for Health Statistics: (www.cdc.gov)

Organisation for Economic Co-operation and Development (OECD) Health Statistics: (www.oecd.org)

Death Rates from Various Health Causes by World Region (Age-Standardized, per 100,000)

Region Age-Standardized Death Rate (per 100,000)
Australia 338.7
Canada 362.5
Western Europe (Excl. Россия Rossiya (Russia)) 370.6
United States 510.4
中国 Zhongguo (China) 522.8
Central America 541.2
South America 558.7
México 589.3
Middle East 598.1
Asia (Excl. 中国 Zhongguo (China)) 634.2
Other Regions 643.0
Россия Rossiya (Russia) 681.4
Africa 812.4

Note: Regional figures represent weighted averages of country-level data for countries in each region with populations over 1 million people. Data year: 2021. Source: WHO Global Health Observatory.

Section 2: What Other Countries Have Done to Decrease Their Death Rates from Various Health Causes

The 8 Top Rated Countries with the Lowest Death Rates from Various Health Causes

Rank Country Age-Standardized Death Rate (per 100,000)
1 日本 Nippon (Japan) 296.0
2 한국 Hanguk (South Korea) 307.5
3 Suisse or Schweiz (Switzerland) 315.2
4 España (Spain) 322.1
5 Italia (Italy) 333.4
6 Australia 338.7
7 ישראל Yisra'el (Israel) 342.3
8 République française (France) 348.9

Nippon (Japan)

Nippon's remarkably low death rate results from a combination of cultural practices, government policy, and universal health care access. Nippon operates a universal health insurance system under the National Health Insurance (NHI) Act, requiring all residents to enroll.

The Ministry of Health, Labour and Welfare (MHLW) (www.mhlw.go.jp) enforces stringent food safety regulations and nutritional labeling standards.

Nippon's Health Nippon 21 initiative promotes preventive care, mental health, and chronic disease management at the national level.

Municipal governments provide regular health screenings (tokutei kenshin) for residents over 40, enabling early detection of metabolic syndrome, cardiovascular disease, and cancer.

The traditional Japanese diet, characterized by low saturated fat, high vegetable consumption, and fish-based proteins, is closely linked to low cardiovascular mortality rates.

Nippon also has one of the highest rates of physician visits per capita and a robust ambulatory care system.

The National Cancer Center Nippon (www.ncc.go.jp) coordinates cancer prevention and early detection programs.

Nippon's long-term care insurance system supports elderly residents, reducing mortality from neglected age-related conditions.

Hanguk (South Korea)

www.nhis.or.krHanguk has achieved dramatic reductions in mortality through rapid expansion of universal health coverage under the National Health Insurance Service (NHIS) ().

The government implemented the National Cancer Screening Program in 1999, dramatically improving early detection of stomach, colorectal, breast, cervical, and liver cancers.

The Hanguk Centers for Disease Control and Prevention (KCDC) (kdca.go.kr) coordinates national infectious disease surveillance and chronic disease management programs.

Hanguk's Health Promotion Act mandates tobacco control, physical activity promotion, and nutrition programs.

The Ministry of Health and Welfare (mohw.go.kr) oversees the National Health Promotion Fund, which finances anti-smoking campaigns, alcohol reduction programs, and mental health services.

Hanguk has invested heavily in digital health infrastructure, with electronic health records covering virtually all citizens and enabling data-driven public health interventions.

Occupational health regulations enforced by the Hanguk Occupational Safety and Health Agency (KOSHA) (kosha.or.kr) have significantly reduced workplace-related mortality.

Schweiz (Switzerland)

Schweiz's low death rate reflects a highly decentralized but comprehensive health care system combining mandatory private health insurance with strong federal regulation.

The Federal Office of Public Health (FOPH) (www.bag.admin.ch) sets national health policy and oversees communicable disease prevention, environmental health, and health promotion.

Under the Federal Health Insurance Act (KVG/LAMal), all residents could carry basic health insurance, ensuring near-universal coverage. Schweiz invests heavily in primary care, with a strong general practitioner network that emphasizes preventive services and chronic disease management.

The Schweiz Cancer League (www.krebsliga.ch) and Schweiz Heart Foundation (www.swissheart.ch) conduct national awareness and prevention campaigns.

Schweiz has stringent environmental protection standards under the Federal Office for the Environment (BAFU) (www.bafu.admin.ch), reducing mortality from air and water pollution.

The country's strong occupational safety laws are enforced by SUVA (www.suva.ch), the national accident insurance fund.

Schweiz has also implemented progressive tobacco legislation, including a comprehensive tobacco products act that restricts advertising and requires plain packaging.

España (Spain)

www.sanidad.gob.esEspaña's public health system (Sistema Nacional de Salud, SNS) provides universal coverage to all citizens and legal residents, coordinated by the Ministry of Health ().

España's Mediterranean diet, rich in olive oil, legumes, fish, fruits, and vegetables, is scientifically associated with reduced cardiovascular mortality and longer life expectancy.

The España National Health Survey monitors population health trends and guides preventive policy.

Regional governments (comunidades autonomas) operate primary health care centers (centros de salud) offering free preventive screenings, vaccinations, and chronic disease management.

España's tobacco control has advanced significantly under the Tobacco Control Law, which prohibits smoking in workplaces, public spaces, and near educational facilities.

The España Society of Cardiology (www.secardiologia.es) and the España Society of Oncology collaborate with government agencies on evidence-based prevention programs.

The National Epidemiology Center (www.isciii.es) conducts ongoing research linking environmental, behavioral, and genetic factors to mortality patterns.

Italia (Italy)

Italia's Servizio Sanitario Nazionale (SSN) provides universal health care financed by general taxation and administered by 21 regional health authorities.

The Italian National Institute of Health (Istituto Superiore di Sanita, ISS) (www.iss.it) directs national public health research and policy. Italia's adherence to the Mediterranean diet is one of the strongest contributors to its low cardiovascular mortality.

The National Prevention Plan (Piano Nazionale della Prevenzione, PNP) sets targets for reducing preventable chronic disease, cancer incidence, and premature mortality through evidence-based interventions.

Italia's tobacco control framework includes a ban on smoking in enclosed public spaces, restrictions on advertising, and mandatory health warnings.

The Italia Association for Cancer Research (AIRC) (www.airc.it) funds cancer prevention, detection, and treatment research. Italia environmental protection laws, enforced by the Institute for Environmental Protection and Research (ISPRA) (www.isprambiente.gov.it), limit population exposure to harmful pollutants.

Strong social cohesion and family support networks have been identified as protective factors against mental health-related and age-related mortality in Italian populations.

Australia

www.health.gov.auAustralia operates Medicare, a universal public health insurance system providing all citizens and permanent residents with access to subsidized medical services, managed by the Department of Health and Aged Care ().

The Australian Institute of Health and Welfare (AIHW) (www.aihw.gov.au) collects, analyzes, and reports health data to guide national policy.

Australia's National Preventive Health Strategy 2021-2030 focuses on addressing chronic disease risk factors including tobacco use, physical inactivity, unhealthy diet, and excessive alcohol consumption.

The Australian Cancer Council (www.cancer.org.au) operates nationally recognized cancer prevention and early detection programs, including the national bowel cancer screening program. Australia has one of the world's strictest tobacco control regimes, including standardized plain packaging legislation enacted in 2012 and enforced by the Department of Health. Environmental health protections under the Environment Protection and Biodiversity Conservation Act limit mortality from pollution.

The Australian Commission on Safety and Quality in Health Care (www.safetyandquality.gov.au) sets national standards for clinical care quality to minimize preventable deaths.

Yisra'el (Israel)

Yisra'el provides universal health care through four competing, non-profit Health Maintenance Organizations (HMOs) regulated under the National Health Insurance Law (1994).

The Ministry of Health (www.health.gov.il) mandates a comprehensive benefits basket (sal habiut) covering preventive, curative, and rehabilitative services. Yisra'el's HMO system emphasizes preventive care, with high rates of vaccination, cancer screening, and chronic disease management.

Maccabi Health Services, Clalit Health Services, and other HMOs operate data-driven population health management programs that identify high-risk individuals and intervene proactively. Yisra'el has high rates of physician training and a robust research-driven medical culture supported by institutions such as the Weizmann Institute of Science (www.weizmann.ac.il) and Hebrew University-Hadassah Medical Center. Yisra'el's environmental health policies, coordinated by the Ministry of Environmental Protection (www.gov.il/en/departments/ministry_of_environmental_protection), limit air and water pollution exposure.

Community-based social cohesion programs and a strong public health workforce contribute to Yisra'el's relatively low mortality across demographic groups.

République française (France)

République française's Assurance Maladie system provides universal health insurance, with the government covering approximately 77% of total health care costs.

The Ministry of Health and Prevention (sante.gouv.fr) coordinates national health policy, supported by Sante publique République française (www.santepubliquefrance.fr), the national public health agency.

République française has implemented successive National Cancer Plans (Plan Cancer) since 2003, dramatically improving early detection and treatment outcomes.

The National Agency for Food, Environmental and Occupational Health and Safety (ANSES) (www.anses.fr) regulates food safety and environmental health risks.

République française's tobacco control strategy includes plain packaging requirements, sales restrictions to minors, and taxation to reduce consumption.

The République française National Nutrition and Health Program (PNNS) promotes balanced diet and physical activity to reduce cardiovascular and metabolic disease mortality.

République française has a dense primary care network with strong emphasis on preventive medicine, and benefits from the protective health effects of the Mediterranean-influenced French diet.

The High Authority for Health (HAS) (www.has-sante.fr) sets national clinical guidelines and evaluates health technologies to ensure evidence-based care delivery.

Section 3: What the U.S. Could Do to Decrease Its Death Rates from Various Health Causes

The United States faces a complex, multifaceted mortality challenge driven by chronic disease, substance use, mental health crises, socioeconomic disparities, and a fragmented health care system. Comprehensive, coordinated action across government, private, and civil society sectors is required to meaningfully reduce preventable deaths.

Government Agencies:

The Centers for Disease Control and Prevention (CDC) (www.cdc.gov) could dramatically expand its public health infrastructure investment, increase chronic disease prevention funding, scale evidence-based community health programs, and improve national disease surveillance capabilities.

The CDC's Office of Public Health Preparedness and Response could increase coordination with state and local health departments.

The National Institutes of Health (NIH) (www.nih.gov) could prioritize funding for research on preventable mortality causes including cardiovascular disease, cancer, diabetes, and substance use disorders.

The Food and Drug Administration (FDA) (www.fda.gov) could strengthen nutritional labeling requirements, accelerate approval of life-saving therapeutics, enforce stricter regulations on addictive substances including tobacco and alcohol, and expand oversight of the food supply to reduce harmful additives.

The Centers for Medicare and Medicaid Services (CMS) (www.cms.gov) could expand Medicaid eligibility, increase reimbursement rates for preventive services, mandate coverage of evidence-based screening programs, and reduce administrative barriers to care access.

The Health Resources and Services Administration (HRSA) (www.hrsa.gov) could fund expansion of Federally Qualified Health Centers (FQHCs) to serve underserved communities, and increase the primary care workforce pipeline.

The Department of Veterans Affairs (VA) (www.va.gov) could continue expanding mental health services, suicide prevention programs, and comprehensive chronic disease management for veterans.

The Environmental Protection Agency (EPA) (www.epa.gov) could enforce and strengthen air quality standards to reduce pollution-related respiratory and cardiovascular mortality.

The Substance Abuse and Mental Health Services Administration (SAMHSA) (www.samhsa.gov) could expand access to medication-assisted treatment (MAT) for substance use disorders and scale mental health crisis intervention infrastructure.

Government Officials:

The President and executive branch could designate reducing preventable mortality as a top national priority, directing interagency coordination and sustained budget increases for public health.

The Secretary of Health and Human Services could convene a National Commission on Preventable Mortality to develop evidence-based recommendations and measure progress annually.

Members of Congress could pass legislation expanding the Affordable Care Act to achieve universal coverage, fund Medicaid expansion in all states, enact comprehensive tobacco and e-cigarette regulations, strengthen mental health parity enforcement, and authorize sustained investment in public health infrastructure.

State governors and legislatures could expand Medicaid in holdout states, fund community health programs, pass tobacco control legislation, strengthen environmental protections, and implement evidence-based opioid response strategies.

County and municipal officials could invest in social determinants of health including affordable housing, food access, safe recreational spaces, and economic opportunity programs that reduce mortality-associated poverty and inequality.

Corporations and Private Sector:

Employers could expand employee health benefits to include comprehensive preventive care, mental health services, substance use treatment, and chronic disease management programs.

Major food and beverage manufacturers could voluntarily reduce sodium, sugar, and trans-fat content in products and adopt front-of-package nutritional labeling systems aligned with public health recommendations.

Health insurance companies could eliminate cost-sharing barriers for preventive screenings, expand telehealth access, and develop value-based payment models that reward health outcomes over service volume.

Pharmaceutical companies could invest in affordable chronic disease medications, expand patient assistance programs, and collaborate with federal agencies on evidence-based prescribing guidelines to reduce opioid overprescription.

Technology companies could develop and deploy digital health tools, remote monitoring platforms, and AI-driven population health management systems that enable earlier identification of high-risk individuals.

Media and entertainment corporations could promote health literacy, combat health misinformation, and adopt responsible standards for advertising unhealthy products, particularly to children and adolescents.

Private Individuals and Civil Society:

Individual Americans could be empowered to make health-promoting choices through accessible, culturally competent health education.

Community organizations, faith communities, and civic groups could engage in peer health education, social support networks, and advocacy for equitable health resources.

Academic and research institutions could collaborate with government and community partners to develop, evaluate, and disseminate evidence-based health promotion interventions.

Non-profit health organizations including the American Heart Association (www.heart.org), American Cancer Society (www.cancer.org), and American Diabetes Association (www.diabetes.org) could scale community-based prevention programs, policy advocacy, and public awareness campaigns.

Medical and public health professional associations could advocate for evidence-based policy, eliminate health care disparities, and lead continuing medical education efforts focused on preventive care and chronic disease management.

Individuals from all walks of life could participate in community health initiatives, advocate to elected officials for public health funding, and support policies that create equitable conditions for health for all Americans.

Section 4: References

The following organizations and sources provided data, research, and policy guidance used throughout this document:

World Health Organization (WHO) - Global Health Observatory: (www.who.int)

Institute for Health Metrics and Evaluation (IHME) - Global Burden of Disease: (www.healthdata.org)

Centers for Disease Control and Prevention (CDC): (www.cdc.gov)

National Institutes of Health (NIH): (www.nih.gov)

Organisation for Economic Co-operation and Development (OECD) Health Statistics: (www.oecd.org)

Commonwealth Fund - International Health Policy Survey: (www.commonwealthfund.org)

American Heart Association: (www.heart.org)

American Cancer Society: (www.cancer.org)

American Diabetes Association: (www.diabetes.org)

Sante publique République française (French Public Health Agency): (www.santepubliquefrance.fr)

Health Resources and Services Administration (HRSA): (www.hrsa.gov)

Substance Abuse and Mental Health Services Administration (SAMHSA): (www.samhsa.gov)

Australian Institute of Health and Welfare (AIHW): (www.aihw.gov.au)

National Cancer Center Nippon: (www.ncc.go.jp)

Korean Centers for Disease Control and Prevention (KCDC): (kdca.go.kr)

Italian National Institute of Health (ISS): (www.iss.it)

Federal Office of Public Health Schweiz (FOPH): (www.bag.admin.ch)

Ministry of Health España: (www.sanidad.gob.es)

Yisra'el Ministry of Health: (www.health.gov.il)

High Authority for Health République française (HAS): (www.has-sante.fr)

Section 5: U.S. Organizations Advocating to Improve Mortality from Disease

Organization Name Contact Information Primary Activity in This Area
Centers for Disease Control and Prevention (CDC) www.cdc.gov
1-800-232-4636
Federal agency monitoring disease mortality trends, funding prevention programs, and providing public health guidance to reduce deaths from leading diseases. CDC's Prevention Research Centers and National Center for Chronic Disease Prevention directly fund and implement the evidence-based programs that reduce disease mortality across all 50 states.
American Heart Association (AHA) www.heart.org
1-800-242-8721
Leading voluntary health organization fighting heart disease and stroke — the top causes of U.S. disease mortality — through research funding, advocacy, and public education. Has invested over $5 billion in cardiovascular research and advocates for policies on tobacco, diet, and health care access that directly reduce disease mortality.
American Cancer Society (ACS) www.cancer.org
1-800-227-2345
Nation's largest cancer organization, reducing cancer mortality through research investment, patient navigation, and advocacy for expanded screening and treatment access. Publishes the authoritative Cancer Statistics report documenting annual mortality trends and has contributed to a 33% decline in cancer death rates since 1991 through advocacy and research.
Trust for America's Health (TFAH) www.tfah.org
info@tfah.org
(202) 223-9870
Advocates for robust federal and state public health investments addressing the chronic and infectious disease drivers of preventable mortality. Publishes annual Pain in the Nation reports documenting preventable disease mortality and calls for increased CDC chronic disease prevention funding.
National Academies of Sciences, Engineering, and Medicine — Health and Medicine Division www.nationalacademies.org/hmd
(202) 334-2000
Produces definitive evidence reviews and policy recommendations on reducing preventable disease mortality, including landmark reports on cancer care, cardiovascular prevention, and chronic disease management. Its reports are the highest-authority scientific reference for federal agency and Congressional policymaking on disease mortality reduction.
Resolve to Save Lives resolvetosavelives.org International public health initiative working to prevent millions of premature deaths from cardiovascular disease and infectious disease epidemics through evidence-based programs and government advocacy. Established by former CDC Director Tom Frieden, it focuses on high-impact, scalable interventions with the largest potential to reduce disease mortality.
American Diabetes Association (ADA) www.diabetes.org
1-800-342-2383
Leads the fight against diabetes — a major driver of cardiovascular, kidney, and neurological disease mortality — through research, advocacy, and community programs. Advocates for expanded diabetes prevention program access, insulin affordability, and coverage of diabetes management technologies that directly reduce mortality from diabetes-related disease.

Section 6: Individuals Advocating to Improve Mortality from Disease

Name, Title & Contact Selected Publications on Mortality from Disease
Christopher J.L. Murray, MD, DPhil
Director, Institute for Health Metrics and Evaluation (IHME), University of Washington
cjlm@uw.edu
(1) "Measuring the Global Burden of Disease," New England Journal of Medicine, 2013 — Described the methods and findings of the Global Burden of Disease study, the world's most comprehensive assessment of mortality and disability from all diseases and injuries across 190+ countries..

(2) "Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death," The Lancet, 2016 — GBD 2015 cause-of-death analysis providing the definitive global picture of disease mortality trends and identifying the interventions with the greatest potential to reduce premature death..

(3) "US Health in International Perspective: Shorter Lives, Poorer Health," National Academies Press, 2013 — Comprehensive analysis of U.S. disease mortality relative to peer nations, documenting the U.S. health disadvantage and recommending policy investments to reduce preventable deaths..
Ezekiel J. Emanuel, MD, PhD
Vice Provost for Global Initiatives and Co-Director, Healthcare Transformation Institute, University of Pennsylvania; Former White House Health Policy Advisor
zekeemanuel@wharton.upenn.edu
(1) "Reinventing American Health Care: How the Affordable Care Act Will Improve Our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System," PublicAffairs, 2014 — Comprehensive analysis of how health system design choices — including coverage gaps and perverse incentives — drive preventable disease mortality and proposed reforms to improve outcomes..

(2) "Why American Patients Bear So Much of the Burden of Disease," The Atlantic, 2018 — Analyzed how inadequate primary care investment, insurance barriers, and social determinant neglect produce preventable disease mortality rates far above those in comparable nations..

(3) "Which Countries Have the Best Health Care?," PublicAffairs, 2020 — Compared 11 countries' health systems on disease mortality outcomes, identifying the policies — universal coverage, primary care investment, prevention funding — that most effectively reduce preventable deaths..
Harvey Fineberg, MD, PhD
President, Gordon and Betty Moore Foundation; Former President, National Academy of Medicine; Former Dean, Harvard School of Public Health
(1) "Shaping Science to Improve Global Health: A Report from the Commission on Creating a Global Community of Science for Health," National Academy of Medicine, 2015 — Proposed a global research coordination framework to accelerate translation of disease prevention discoveries into reduced mortality in both high- and low-income countries..

(2) "Public Health in the Time of Ebola," Science, 2014 — Analyzed the institutional and structural failures that allowed the 2014 Ebola epidemic to kill thousands before containment, informing reforms to global infectious disease mortality prevention..

(3) "Pandemic Preparedness and Response: Lessons from the H1N1 Influenza of 2009," New England Journal of Medicine, 2014 — Reviewed the United States' response to the 2009 influenza pandemic and identified systemic improvements needed to reduce infectious disease mortality in future outbreaks..
Thomas R. Frieden, MD, MPH
President and CEO, Resolve to Save Lives; Former Director, Centers for Disease Control and Prevention
info@resolvetosavelives.org
(1) "A Framework for Public Health Action: The Health Impact Pyramid," American Journal of Public Health, 2010 — Proposed a five-level public health action framework prioritizing social determinants and policy-based interventions as the most powerful levers for reducing disease mortality at scale..

(2) "Saving More Than Half a Million Lives per Year: Successes of Cardiovascular Disease Prevention Programs," JAMA Cardiology, 2020 — Documented the global impact of blood pressure and tobacco control programs in preventing cardiovascular mortality, providing evidence for scaling proven interventions..

(3) "Evidence for Health Decision Making — Beyond Randomized, Controlled Trials," New England Journal of Medicine, 2017 — Argued for broader evidence standards in public health practice, advocating for implementation of well-evidenced interventions even without RCT confirmation when the disease mortality burden is severe..
Margaret A. Hamburg, MD
Former Commissioner, U.S. Food and Drug Administration; Foreign Secretary, National Academy of Medicine
(1) "Science and Regulation: FDA's Critical Role in Reducing Disease Mortality," Science, 2014 — Described FDA regulatory decisions as pivotal determinants of disease mortality through drug approvals, food safety enforcement, and tobacco regulation..

(2) "Antimicrobial Resistance and Disease Mortality: A Growing Threat to Public Health," JAMA, 2015 — Documented the projected mortality burden from antimicrobial resistance and called for coordinated federal action to preserve antibiotic effectiveness and develop new treatments..

(3) "Global Health and the Outbreak of Disease in the 21st Century," Academic Medicine, 2015 — Analyzed how global interconnectedness requires strengthened international disease surveillance and response systems to prevent cross-border disease mortality..
Paul Farmer, MD, PhD (1959–2022)
Kolokotrones University Professor of Global Health and Social Medicine, Harvard Medical School; Co-Founder, Partners in Health
(1) "Infections and Inequalities: The Modern Plagues," University of California Press, 1999 — Documented how poverty and inequality drive infectious disease mortality in both low-income countries and impoverished U.S. communities, arguing that social justice is inseparable from disease prevention..

(2) "Pathologies of Power: Health, Human Rights, and the New War on the Poor," University of California Press, 2003 — Argued that structural violence — poverty, racism, and lack of health care — is the primary driver of preventable disease mortality among the world's poor..

(3) "To Repair the World: Paul Farmer Speaks to the Next Generation," University of California Press, 2013 — Collection of addresses articulating the ethical and practical case for global health equity as the foundation for reducing disease mortality in underserved communities..
Renu Gupta, MD, MPH
Deputy Director for Science, Office of Noncommunicable Diseases, Injury, and Environmental Health, CDC
(1) "Noncommunicable Disease Mortality Trends and Prevention Policy in the United States," Preventing Chronic Disease, 2018 — Documented trends in U.S. mortality from noncommunicable diseases and evaluated the policy interventions with the greatest evidence for reducing preventable chronic disease deaths..

(2) "Community Preventive Services Guide for Chronic Disease Mortality Reduction," American Journal of Preventive Medicine, 2017 — Compiled systematic evidence reviews for community-level interventions proven to reduce mortality from cardiovascular disease, diabetes, and cancer in U.S. populations..

(3) "Addressing Disparities in Noncommunicable Disease Mortality Through Primary Prevention," Annals of Epidemiology, 2020 — Analyzed racial and geographic disparities in preventable disease mortality and identified targeted prevention policies most likely to close the mortality gap..

Frequently Asked Questions

How does the US death rate compare to other high-income countries?

The US ranks 35th out of the 35 lowest-death-rate countries with populations over 5 million, with an age-standardized death rate of approximately 510.4 per 100,000. In 2023, the overall US age-adjusted death rate was approximately 733.8 per 100,000, significantly higher than comparable wealthy nations.

What are the main reasons the US has a higher death rate than peer nations?

Key factors include high rates of chronic diseases such as cardiovascular disease, diabetes, and obesity, along with elevated rates of drug overdose deaths driven by the opioid epidemic. Additional contributors include limited universal health care access, firearm-related mortality, socioeconomic disparities, and lower public health infrastructure investment compared to peer nations.

What has Japan done to achieve one of the world's lowest death rates?

Japan operates a universal health insurance system requiring all residents to enroll, combined with a national Health Nippon 21 initiative promoting preventive care and chronic disease management. Municipal governments provide regular health screenings for residents over 40, and the traditional Japanese diet low in saturated fat and high in vegetables and fish is closely linked to low cardiovascular mortality.

How does universal health care access affect a country's death rate?

Countries with universal health care systems, like Japan and South Korea, achieve earlier disease detection, more consistent preventive care, and better chronic disease management, all of which reduce preventable deaths. The US fragmented system leaves significant gaps in access and quality, particularly for lower-income populations, contributing to higher mortality rates.

What role do preventive screenings play in reducing national death rates?

Regular preventive screenings, such as Japan's tokutei kenshin metabolic screenings for adults over 40, enable early detection of conditions like cardiovascular disease, metabolic syndrome, and cancer before they become fatal. Early detection dramatically improves treatment outcomes and reduces overall mortality at the population level.

Where can I find reliable data on US and global death rates by cause?

Reliable sources include the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics at cdc.gov/nchs, the World Health Organization (WHO) Global Health Observatory at who.int/data/gho, the Institute for Health Metrics and Evaluation Global Burden of Disease study at healthdata.org, and Organisation for Economic Co-operation and Development (OECD) Health Statistics at oecd.org/health/health-data.htm.

About the Author

Ronald Bonfilio has devoted his career to public service spanning more than five decades. His service began with the U.S. Army from 1966 to 1968, where he conducted medical laboratory research at Fort Detrick and at the Walter Reed Army Institute of Research. He subsequently held a distinguished series of federal positions, including roles with the National Cancer Institute, the National Institutes of Health, the U.S. Agency for International Development (Vietnam), the Special Inspector General for Iraq Reconstruction, and the U.S. State Department (Iraq), where he served as a Senior Economic Advisor and Agricultural Advisor. He also served 15 years with the U.S. Government Accountability Office as a Program Analyst and Auditor.

Ronald Bonfilio holds a degree in Economics from the University of Maryland, and degrees in Chemistry and a Master of Business Administration from the University of Massachusetts. He is a former Certified Public Accountant.